Iran in Wikipedia
In 2012, 30,000 people came to Iran to receive medical treatment. In 2015, It is estimated that between 150,000 and 200,000 health tourists come to Iran, and this figure is expected to rise to 500,000 a year.
Iran is low endemicity for HBV and HCV infections and there is a unique experiences regarding control of these infections that can present to the peoples in Middle East countries. The pharmaceutical companies in Iran produces all of drugs are needed for control of HCV and HBV infection such as Tenefovir, Peg Interferon, Sofosbovir, Ledipasvir, Daclatasvir with very low prizes and high efficiency. Sadeghi F, Salehi-Vaziri M, Almasi-Hashiani A, Gholami-Fesharaki M, Pakzad R, Alavian SM. Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis. Hepat Mon. 2016; 16(4):e35558.
In below link